Business Description
Honz Pharmaceutical Co Ltd
NAICS : 325412
ISIN : CNE100000QM6
Compare
Compare
Traded in other countries / regions
300086.China IPO Date
2010-05-26Description
Honz Pharmaceutical Co Ltd is engaged in providing medicines for children. The company's practice in this sector mainly involves the research and development, manufacturing and sales of pediatric medicines. It has automated and intelligent manufacturing bases in Hainan, Beijing, Hebei, Liaoning, and Guangdong.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.22 | |||||
| Equity-to-Asset | 0.61 | |||||
| Debt-to-Equity | 0.41 | |||||
| Debt-to-EBITDA | -27.64 | |||||
| Interest Coverage | 0.12 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 1.96 | |||||
| Beneish M-Score | -2.52 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -7.2 | |||||
| 3-Year EBITDA Growth Rate | 8.9 | |||||
| 3-Year EPS without NRI Growth Rate | -6.2 | |||||
| 3-Year FCF Growth Rate | 40.5 | |||||
| 3-Year Book Growth Rate | -3.6 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 36.87 | |||||
| 9-Day RSI | 42.32 | |||||
| 14-Day RSI | 44.11 | |||||
| 6-1 Month Momentum % | -29.6 | |||||
| 12-1 Month Momentum % | -26.21 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.46 | |||||
| Quick Ratio | 0.84 | |||||
| Cash Ratio | 0.29 | |||||
| Days Inventory | 340.25 | |||||
| Days Sales Outstanding | 41.85 | |||||
| Days Payable | 113.68 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | 2.13 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 61.17 | |||||
| Operating Margin % | 0.43 | |||||
| Net Margin % | -7.52 | |||||
| FCF Margin % | 6.44 | |||||
| ROE % | -3.81 | |||||
| ROA % | -2.36 | |||||
| ROIC % | 0.21 | |||||
| ROC (Joel Greenblatt) % | -1.7 | |||||
| ROCE % | -1.09 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shiller PE Ratio | 457 | |||||
| PS Ratio | 3.08 | |||||
| PB Ratio | 1.58 | |||||
| Price-to-Tangible-Book | 1.9 | |||||
| Price-to-Free-Cash-Flow | 47.59 | |||||
| Price-to-Operating-Cash-Flow | 31.5 | |||||
| EV-to-EBIT | -129.27 | |||||
| EV-to-EBITDA | -129.27 | |||||
| EV-to-Revenue | 3.7 | |||||
| EV-to-FCF | 59.88 | |||||
| Price-to-Median-PS-Value | 0.67 | |||||
| Earnings Yield (Greenblatt) % | -0.77 | |||||
| FCF Yield % | 2.1 | |||||
| Forward Rate of Return (Yacktman) % | -13.64 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Honz Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 669.709 | ||
| EPS (TTM) (Â¥) | -0.112 | ||
| Beta | 1.52 | ||
| Volatility % | 25.99 | ||
| 14-Day RSI | 44.11 | ||
| 14-Day ATR (Â¥) | 0.201081 | ||
| 20-Day SMA (Â¥) | 4.626 | ||
| 12-1 Month Momentum % | -26.21 | ||
| 52-Week Range (Â¥) | 3.75 - 7.2 | ||
| Shares Outstanding (Mil) | 450 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Honz Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Honz Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Honz Pharmaceutical Co Ltd Frequently Asked Questions
What is Honz Pharmaceutical Co Ltd(SZSE:300086)'s stock price today?
The current price of SZSE:300086 is ¥4.57. The 52 week high of SZSE:300086 is ¥7.20 and 52 week low is ¥3.75.
When is next earnings date of Honz Pharmaceutical Co Ltd(SZSE:300086)?
The next earnings date of Honz Pharmaceutical Co Ltd(SZSE:300086) is .
Does Honz Pharmaceutical Co Ltd(SZSE:300086) pay dividends? If so, how much?
Honz Pharmaceutical Co Ltd(SZSE:300086) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers